Search Results

GPCR Community Survey Help us build the next evolution of the GPCR Ecosystem — together. Build stronger connections between academia and industry. Expand our shared knowledge base Support students and researchers entering the field Together, we’re building

GPCR buttons. GPCR button. GPCR Buttons. By using a Dr. GPCR button, Publishers give Dr. GPCR button. GPCR buttons.

MBA from the University of North Carolina, and completed the General Management Program at Harvard Business Podcast Episode Baking Molecules, Building Probes: When Chemists Think Like Biologists Episode #168 •

Cross-functional Team Alignment Scaling Protocols & Decision Architecture From Chaos to Scale Timeline Strategy built Build clarity → align people, process, priorities. 3. Scale with confidence → expand without burnout. Building the Strategic Backbone of GPCR Innovation In the rapidly evolving GPCR field, scientific progress organizations: ✅ Clarify vision and direction ✅ Translate research milestones into measurable objectives ✅ Build

Oct 2021 — Featured at ERNEST with Where All GPCRs Are Created Equal . 2022 Building Momentum Podcast

courses connect experts, students, and industry professionals through authentic, instructor-led learning—built We will then have a short call and send you the our Instructor Intake Form — it’s how we build your profile

participating in the Affiliates Program: “Cash-back” or voucher sites (websites that offer rewards for buying GPCR conducts business Affiliate Policy Content and Conduct Policy Content Guidance Privacy Policy Terms

Buchner’s group at the University of Wuerzburg. Shortly after receiving my PhD, I joined Dr.

About Gavin Zhang Gavin is a currently a director of business and operations at Novoprotein Scientific

We’re building together, with input from across the field. About Dr. News See Why it Matters 6,600+ followers 200+ Research Labs 1,500+ Scientists 50+ Biotech Companies Built What We Believe The Ecosystem was built with five key beliefs: Scientific rigor first This is a space Transparency builds trust We're open about who we are and what we do. We built Dr.

The Foundry is built for GPCR biotech companies at the discovery stage . 🔬 Validate your first target aligned to your biotech’s goals and timeline → Book Your Free Strategy Call Specialized Training — Build Build confidence through expert-led lessons, case studies, and proven experimental strategies. → Explore Build credibility and visibility among scientists, biotechs, and CRO partners worldwide. Build collective expertise and alignment that accelerates discovery outcomes. → Explore Dr.

Activation takes 3–10 business days .

Become our Brand Ambassador Our vision is to build the best platform for the GPCR community and help you the scientists and business owners to share their experiences with others, get help, and find the perfect tools, colleagues, build their strategy and advance our field. blogging, guest blogging, - Podcast, video, vlog - Social media sharing, - YouTube & TikTok channels, - Business It will be a remarkable journey and fun to build together the "next-generation" platform for the B2B

Fast Track My Discovery The wrong CRO—or wrong experiments—can burn months and millions You're not here Build plans aligned to go/no-go moments, not busywork Drive regular check-ins that produce clear, actionable

Built for founders who prefer clarity over chaos and confusion. Biotech Decision Vault by Attila Foris Strategic Business & Operating Systems Advisor Dr.

with receptor systems, ligand design, efficacy modeling, or signaling pathways, these sessions are built

Purpose-Built for Live-Cell Internalization Assays The pHSense™ family of europium-labeled, pH-sensitive radioligand binding, cAMP, IP-One, and phospho-protein assays (ERK, AKT, CREB, MEK), this toolkit is built Build Your GPCR Assay Workflow Meet the Team behind pHSense™ Eric TRINQUET Sr Director Life Sciences He joined Revvity (then Cisbio) in 2016 as part of the scientific marketing effort to build brand recognition A Tool Designed for Real Research Needs Built on more than two decades of GPCR assay innovation, pHSense

We also know that you are busy, which is why we designed this short survey that should take you 5 minutes

Streamline workflows and improve scientific execution to increase client satisfaction and secure repeat business ensuring every strategic decision efficiently propels your program forward and aligns with critical business Core Values: The Foundation of Every Successful Partnership My advisory is built on principles that ensure Whether it's optimizing CRO selection, building robust internal capabilities, or translating complex

Built for founders who prefer clarity over chaos and confusion. Biotech Decision Vault by Attila Foris Strategic Business & Operating Systems Advisor Dr.

The company's portfolio is built around high-affinity, selective fluorescent ligands for GPCRs, supporting

It’s an eight-year-plus haul with built-in uncertainty. Serafini Pivoting: Redefining the Pain Research Playbook Looking ahead, Serafini’s vision is bold: build “Start from the end — from the clinic — and then build backwards.” — Alex Serafini Key Takeaway Innovation

Connect With The GPCR Community You've built incredible CRO services. We are building the world's first CRO Service-focused GPCR bank. scientists who are actively looking for tools like yours, without the noise of general platforms. 🤝 Build

Alessandro Nicoli shares how he models olfactory GPCRs with AlphaFold, mentors students, and builds science Build predictive models to discover new ligands .

structural biology—and where it still falls short Advice for junior scientists: what really matters when building That moment launched a career built around using computational tools to answer big biological questions Jens is passionate about prediction over explanation: building models that can guide experiments, not

Johannes Broichhagen shares how his lab builds next-generation fluorescent probes to visualize GPCRs Tried to build assays that behave in living cells—not just on paper.

Caron has received numerous awards including a Burroughs Wellcome Fund Career Award in the Biomedical

If you are entering into this ATS on behalf of a company, business, or other legal entity, you represent GPCR conducts business Affiliate Policy Content and Conduct Policy Content Guidance Privacy Policy Terms

Burixafor, their most advanced clinical candidate, will be in Phase II clinical trial next year.

After switching to biotech, Murat has built cell imaging software and lab robots to accelerate cancer